These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25992488)

  • 21. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.
    Matsui Y; O'Rourke MF; Hoshide S; Ishikawa J; Shimada K; Kario K
    Hypertension; 2012 Jun; 59(6):1132-8. PubMed ID: 22547439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
    Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
    Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    London GM
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S9-S14. PubMed ID: 15592572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
    Savoia C; Touyz RM; Amiri F; Schiffrin EL
    Hypertension; 2008 Feb; 51(2):432-9. PubMed ID: 18195160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
    Yutaka M; Mifune M; Kubota E; Itoh H; Saito I
    Clin Exp Hypertens; 2009 Nov; 31(8):648-56. PubMed ID: 20001457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Analysis of The Effectiveness of Antihypertensive Therapy Including Spironolactone and Eplerenone in Patients With Essential Hypertension and Atrial Fibrillation.
    Abdullaeva GZ; Radzhabova GM; Sherbadalova NH; Pulatova MT; Mashkurova ZT; Alieva RB; Khatamova MN; Ibragimov NN
    Kardiologiia; 2024 Sep; 64(9):70-79. PubMed ID: 39392269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension.
    Sato A; Fukuda S
    J Hum Hypertens; 2010 Jun; 24(6):387-94. PubMed ID: 19865106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension.
    Schneider A; Schwab J; Karg MV; Kalizki T; Reinold A; Schneider MP; Schmieder RE; Schmidt BM
    J Hypertens; 2017 May; 35(5):1086-1092. PubMed ID: 28118280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of losartan on serum uric acid in hypertension treated with a diuretic: the COMFORT study.
    Matsumura K; Arima H; Tominaga M; Ohtsubo T; Sasaguri T; Fujii K; Fukuhara M; Uezono K; Morinaga Y; Ohta Y; Otonari T; Kawasaki J; Kato I; Tsuchihashi T;
    Clin Exp Hypertens; 2015; 37(3):192-6. PubMed ID: 25051056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.
    Weinberger MH; Roniker B; Krause SL; Weiss RJ
    Am J Hypertens; 2002 Aug; 15(8):709-16. PubMed ID: 12160194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure.
    Arnold AC; Okamoto LE; Gamboa A; Black BK; Raj SR; Elijovich F; Robertson D; Shibao CA; Biaggioni I
    Hypertension; 2016 Feb; 67(2):424-9. PubMed ID: 26644241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus.
    Karashima S; Yoneda T; Kometani M; Ohe M; Mori S; Sawamura T; Furukawa K; Yamagishi M; Takeda Y
    Clin Exp Hypertens; 2016; 38(7):565-570. PubMed ID: 27651039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus.
    Joffe HV; Kwong RY; Gerhard-Herman MD; Rice C; Feldman K; Adler GK
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2552-8. PubMed ID: 17488800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms and the distress they cause: comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension.
    Hollenberg NK; Williams GH; Anderson R; Akhras KS; Bittman RM; Krause SL
    Arch Intern Med; 2003 Jul; 163(13):1543-8. PubMed ID: 12860576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial.
    Ando K; Ohtsu H; Uchida S; Kaname S; Arakawa Y; Fujita T;
    Lancet Diabetes Endocrinol; 2014 Dec; 2(12):944-53. PubMed ID: 25466242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
    Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.